FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

424725004: Agalsidase beta (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3688105010 Agalsidase beta (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3688106011 Agalsidase beta en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta Is a Alpha-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase beta Has disposition Hydrolase true Inferred relationship Existential restriction modifier
Agalsidase beta Is a Galactosidase true Inferred relationship Existential restriction modifier
Agalsidase beta Is a Recombinant protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Product containing agalsidase beta Has active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection Has basis of strength substance True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection Has basis of strength substance True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing agalsidase beta in parenteral dose form (medicinal product form) Has active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Agalsidase beta Has active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing only agalsidase beta in parenteral dose form (medicinal product form) Has active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier 1
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) Has active ingredient False Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Agalsidase beta 5mg powder for solution for injection vials 1 vial Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial Has specific active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start